Literature DB >> 15090866

The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans.

Judith A Miller1, James W Scholey.   

Abstract

PURPOSE OF REVIEW: The renin-angiotensin system plays a central role in health and disease but the determinants of renin-angiotensin system activity have not been fully elucidated. Physiologic genomics continues to be an active area of research that emphasizes definition of phenotype and clarification of non-genomic factors that influence the genotype-phenotype correlation. A common variant of the angiotensinogen gene (T235) predicts elevated levels of circulating angiotensinogen, and polymorphisms of this gene have been linked to physiologic responses and to the risk of cardiovascular disease. The angiotensin-converting-enzyme gene insertion/deletion polymorphism, although not considered functional, has been associated with physiologic responses and disease risk in hypertension and diabetes. A polymorphism of the angiotensin type 1 receptor gene, A1166C, has been the focus of several physiologic studies. These authors will focus on mechanistic studies in normal humans and those with diabetes mellitus or hypertension that examine the impact of these polymorphisms on physiologic responses. RECENT
FINDINGS: Recent studies provide divergent results. Many have shown that mediating factors interfere with the genotype-phenotype correlation. Studies in normal individuals and in those with diabetes mellitus have shown that sodium status and glycemia can alter the impact of genotype. In individuals with essential hypertension, the pathway between genotype and physiology can be disrupted by gender and/or race.
SUMMARY: Divergent results in many studies may be attributable to various non-genomic and environmental influences on the pathway between gene polymorphism and physiology. Clarification of these factors should allow a better understanding of genotype-phenotype correlation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090866     DOI: 10.1097/00041552-200401000-00014

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  18 in total

Review 1.  Systems biology and heart failure: concepts, methods, and potential research applications.

Authors:  Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

2.  Association of angiotensin I converting enzyme, angiotensin II type 1 receptor and angiotensin I converting enzyme 2 gene polymorphisms with the dyslipidemia in type 2 diabetic patients of Chinese Han origin.

Authors:  Y Xu; Q Bao; B He; Y Pan; R Zhang; X Mao; Z Tang; L Qu; C Zhu; F Tian; S Wang
Journal:  J Endocrinol Invest       Date:  2011-06-07       Impact factor: 4.256

3.  Genetic polymorphism of ACE and the angiotensin II type1 receptor genes in children with chronic kidney disease.

Authors:  Manal F Elshamaa; Samar M Sabry; Hafez M Bazaraa; Hala M Koura; Eman A Elghoroury; Nagwa A Kantoush; Eman H Thabet; Dalia A Abd-El Haleem
Journal:  J Inflamm (Lond)       Date:  2011-08-23       Impact factor: 4.981

4.  Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study.

Authors:  Wilfried Renner; Markus Nauck; Bernhard R Winkelmann; Michael M Hoffmann; Hubert Scharnagl; Volker Mayer; Bernhard O Boehm; Winfried März
Journal:  J Mol Med (Berl)       Date:  2004-12-15       Impact factor: 4.599

5.  Polymorphisms in the renin-angiotensin system and migraine in women.

Authors:  Markus Schürks; Robert Y L Zee; Julie E Buring; Tobias Kurth
Journal:  Headache       Date:  2008-10-27       Impact factor: 5.887

6.  Genetic variants in the renin-angiotensin system genes are associated with cardiovascular-renal-related risk factors in Mexican Americans.

Authors:  Farook Thameem; V Saroja Voruganti; Xin He; Subrata D Nath; John Blangero; Jean W MacCluer; Anthony G Comuzzie; Hanna E Abboud; Nedal H Arar
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

7.  Angiotensin-converting enzyme gene insertion/deletion polymorphism in Korean patients with systemic sclerosis.

Authors:  Chung Il Joung; Yong Wook Park; Sook Kyoung Kim; Wan Sik Uhm; Tae Hwan Kim; Dae Hyun Yoo
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

8.  Genetic variation in angiotensin-converting enzyme-related pathways associated with sudden cardiac arrest risk.

Authors:  Nona Sotoodehnia; Guo Li; Catherine O Johnson; Rozenn N Lemaitre; Kenneth M Rice; Thomas D Rea; David S Siscovick
Journal:  Heart Rhythm       Date:  2009-06-09       Impact factor: 6.343

9.  Genetic contribution and associated pathophysiology in end-stage renal disease.

Authors:  Suraksha Agrawal; Ss Agarwal; Sita Naik
Journal:  Appl Clin Genet       Date:  2010-08-05

10.  Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation.

Authors:  Dawood Darbar; Alison A Motsinger; Marylyn D Ritchie; James V Gainer; Dan M Roden
Journal:  Heart Rhythm       Date:  2007-02-09       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.